Interviews
Makers of Celliant appoint Mr Foyle as MD
07 Jan '12
2 min read
Hologenix, LLC, makers of Celliant, the leading responsive textile technology for apparel, bedding and veterinary products, announces the recent appointment of Alexander Foyle as Managing Director for Europe, Middle East and Africa. Foyle will oversee an international sales force and will report to Seth Casden, CEO of Hologenix, LLC.
"Mr. Foyle is a proven sales professional with successful marketing and innovation endeavors and an impressive 15 years of international experience," said Seth Casden, CEO of Hologenix, LLC.
"His expertise in the European market will allow him to successfully develop new opportunities for the company and brand as a whole, helping Celliant expand its presence in key markets."
Foyle previously held the role as Managing Director of Deutsche Standards Editionen GmbH, after initially joining the company as Publishing Director in the beginning of 2010. In 2011 Deutsche Standards recorded their best year yet, with prestigious international projects financed amongst others with grants from the German government.
Foyle began his career as an entrepreneur and co-founded the Hanf Medien GmbH, which produced the monthly magazine, "Hanf." He subsequently worked in Sales Director positions for Germany's Konemann publishing group, Parragon GmbH and Marix GmbH.
At these firms, Foyle effectively increased sales at an international level and successfully launched these brands into new markets. Foyle graduated with a BA in European Business Administration from the European Business School in London.
Celliant is a revolutionary, patented technology that harnesses and recycles the body's natural energy through the medium of fibers. Celliant's applied science utilizes a blend of minerals and proprietary ingredients that are embedded into the core of the fiber.
Founded in 2003, Hologenix, LLC, maker of Celliant technology, is committed to creating, developing and bringing to market products that enhance people's lives through new materials.
They strive to deliver the future of healthy innovation through a variety of consumer categories. The Company continues to explore new territories and is currently running FDA-focused, clinical trials to expand into the medical product arena.
"Mr. Foyle is a proven sales professional with successful marketing and innovation endeavors and an impressive 15 years of international experience," said Seth Casden, CEO of Hologenix, LLC.
"His expertise in the European market will allow him to successfully develop new opportunities for the company and brand as a whole, helping Celliant expand its presence in key markets."
Foyle previously held the role as Managing Director of Deutsche Standards Editionen GmbH, after initially joining the company as Publishing Director in the beginning of 2010. In 2011 Deutsche Standards recorded their best year yet, with prestigious international projects financed amongst others with grants from the German government.
Foyle began his career as an entrepreneur and co-founded the Hanf Medien GmbH, which produced the monthly magazine, "Hanf." He subsequently worked in Sales Director positions for Germany's Konemann publishing group, Parragon GmbH and Marix GmbH.
At these firms, Foyle effectively increased sales at an international level and successfully launched these brands into new markets. Foyle graduated with a BA in European Business Administration from the European Business School in London.
Celliant is a revolutionary, patented technology that harnesses and recycles the body's natural energy through the medium of fibers. Celliant's applied science utilizes a blend of minerals and proprietary ingredients that are embedded into the core of the fiber.
Founded in 2003, Hologenix, LLC, maker of Celliant technology, is committed to creating, developing and bringing to market products that enhance people's lives through new materials.
They strive to deliver the future of healthy innovation through a variety of consumer categories. The Company continues to explore new territories and is currently running FDA-focused, clinical trials to expand into the medical product arena.
Hologenix LLC
Popular News
Leave your Comments
Editor’s Pick
Esteemed Clients
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Taiwan Textile Federation (TTF)")
